Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10873 - 10880 of 12011 results
How Would CPSC Function During a Government Shutdown?
September 30, 2013| Blog| Viewpoint
Companions No More: U.S. Department of Labor Extends Minimum Wage and Overtime Protections to Home Health Care Workers
September 30, 2013| Blog| Viewpoint
Government Shutdown Would Pose a Myriad of Issues for Employers
September 30, 2013| Blog| Viewpoint
Google Must Face Most Claims in Keyword Wiretap Class Action
September 28, 2013| Blog| Viewpoint
No More Playing Cute With Non-Solicitation Obligations: First Circuit Court of Appeals Rejects "Customer Called Me First" Argument
September 27, 2013| Blog| Viewpoint
Want to Turn on Your Employer? There’s an App for That.
September 26, 2013| Blog| Viewpoint
Banks Encouraged to Share Information Related to Elder Abuse
September 26, 2013| Blog| Viewpoint
Effect of a Government Shutdown on Medicare, Medicaid, and Other ACA-Related Operations
September 25, 2013| Alert| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|